Skip to content

Draft, not yet released. In stewardship review. Not indexed until the first approved release.

References and record

Every source the edition rests on, the publication record, the corrections log and the open record.

16 min read0 figures1 table0 notesNR-XTECH-NEURO-GLOBAL-2026-BASELINE

목차
  1. ·Edition home
  2. ·Executive summary
  3. 1Neurotechnology is clinical hardware and a new class of personal data
  4. 2Key findings
  5. 3Systems and sectors at baseline
  6. 4Risks and capability
  7. 5Consumer neural data outside medical rules
  8. 6Readings from the other desks
  9. 7The 2027 agenda
  10. 8Systems in depth
  11. A방법론
  12. BData appendix
  13. CReferences and record
    1. C.1 44 sources
    2. C.2 Publication record
    3. C.3 Corrections log
    4. C.4 Open record
    5. C.5 Where this edition sits among the six pillars
  14. ·Complete edition, for print

C.144 sources

NR-CIT-1, editor first. A DOI is linked where the source has one; Nexus records carry a UNI once the catalogue allocates it (NS-1).

  1. 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
  2. 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
  3. 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 6, chapter 8
  4. 4Wairagkar, M. et al., An instantaneous voice synthesis neuroprosthesis, bioRxiv preprint, 19 August 2024 (preprint record read: 256 microelectrodes, one participant with ALS; no quantitative scores in the abstract; the record notes Nature 644(8075), 145 to 152, 2025). Cold Spring Harbor Laboratory, New York. Observation year 2024. Accessed 2026-11-03. Cited in chapter 6, chapter 8
  5. 5Kunz, E.M. et al., Inner speech in motor cortex and implications for speech neuroprostheses, Cell 188(17), 4658 to 4673, published online 14 August 2025 (reference record read: four participants). Cell Press, Cambridge MA. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 7
  6. 6Willett, F.R., Avansino, D.T., Hochberg, L.R., Henderson, J.M. and Shenoy, K.V., High-performance brain-to-text communication via handwriting, Nature 593(7858), 249 to 254, published online 12 May 2021 (reference record read: 90 characters per minute; 94.1% raw online accuracy). Springer Nature, London. Observation year 2021. Accessed 2026-11-03. Cited in chapter 6, chapter 8
  7. 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
  8. 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
  9. 9US Food and Drug Administration (ed.), Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-clinical Testing and Clinical Considerations, final guidance, May 2021 (guidance page read). Center for Devices and Radiological Health, Silver Spring. Observation year 2021. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 4, chapter 6, chapter 8
  10. 10UNESCO (ed.), Recommendation on the Ethics of Neurotechnology (page read: adopted November 2025 at the 43rd session of the General Conference; mandate entrusted by 194 Member States in 2023; the page states no neural data provisions). United Nations Educational, Scientific and Cultural Organization, Paris. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 7, chapter 8
  11. 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
  12. 12US Senate Committee on Commerce, Science, and Transportation (ed.), release on the introduction of the MIND Act, 24 September 2025 (release read: names Colorado, California, Montana and Connecticut as states with neural data laws). US Senate, Washington. Observation year 2025. Accessed 2026-11-03. Cited in chapter 2, chapter 3, chapter 4, chapter 6, chapter 8
  13. 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03. Cited in chapter 2, chapter 3, chapter 4, chapter 8
  14. 14Colorado General Assembly (ed.), HB24-1058 Protect Privacy of Biological Data (bill page read: signed 17 April 2024; effective 7 August 2024). Colorado General Assembly, Denver. Observation year 2024. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 5, chapter 6, chapter 8
  15. 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03. Cited in chapter 2, chapter 4, chapter 6, chapter 7, chapter 8
  16. 16Ministry of Industry and Information Technology and six other bodies (eds.), Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry, MIIT (2025) No. 164, 23 July 2025, English translation by the Center for Security and Emerging Technology, 18 December 2025 (translation page read). Georgetown University, Washington. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 4, chapter 6, chapter 8
  17. 17Cornejo-Plaza, M.I., Cippitani, R. and Pasquino, V., Chilean Supreme Court ruling on the protection of brain activity: neurorights, personal data protection, and neurodata, Frontiers in Psychology 15, 27 February 2024 (reference record read). Frontiers Media, Lausanne. Observation year 2024. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 5, chapter 8
  18. 18Lee, B.H., Even Chile neurorights leave inferred mental data in a gray zone, Stanford Law School Law and Biosciences Blog, 27 April 2026 (blog page read; commentary, not a legal text). Stanford University, Stanford. Observation year 2026. Accessed 2026-11-03. Cited in the summary, chapter 2, chapter 4, chapter 6, chapter 8
  19. 19Szoszkiewicz, L. and Yuste, R., Mental privacy: navigating risks, rights and regulation, EMBO Reports 26(14), 3469 to 3473, published online 25 June 2025 (reference record read; no abstract beyond the subtitle). Springer Nature, London. Observation year 2025. Accessed 2026-11-03. Cited in chapter 6, chapter 8
  20. 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03. Cited in the summary, chapter 1, chapter 2, chapter 3, chapter 4, chapter 6, chapter 7, chapter 8
  21. 21Bublitz, C. et al., A moratorium on implantable non-medical neurotech until effects on the mind are properly understood, Neuroethics 18(3), article 46, 2025 (reference record read: proposes a mental impact assessment, a moratorium and a ban for children). Springer, Dordrecht. Observation year 2025. Accessed 2026-11-03. Cited in chapter 6, chapter 8
  22. 22Ma, X. et al., Using adversarial networks to extend brain computer interface decoding accuracy over time, eLife 12, e84296, 2023 (reference record read). eLife Sciences, Cambridge. Observation year 2023. Accessed 2026-11-03. Cited in chapter 1, chapter 4, chapter 6, chapter 8
  23. 23Wellman, S.M. et al., A materials roadmap to functional neural interface design, Advanced Functional Materials 28(12), 2018 (reference record read; no figures in the abstract). Wiley, Weinheim. Observation year 2018. Accessed 2026-11-03. Cited in chapter 6, chapter 8
  24. 24Feng, Y. et al., Brain-computer interfaces: the dawn of a new era in disease treatment, Exploration 6(3), 2026 (reference record read: electrode biocompatibility and signal resolution named as challenges). Wiley, Beijing. Observation year 2026. Accessed 2026-11-03. Cited in chapter 1, chapter 4, chapter 6, chapter 8
  25. 25California Legislature (ed.), SB 1223 (Becker), Consumer privacy: sensitive personal information: neural data, Chapter 887, Statutes of 2024, chaptered 28 September 2024 (bill record read on CalMatters Digital Democracy; sponsor release of 27 September 2024: signed by the Governor, in effect 1 January 2025; the legislature page returned an access error). California Legislature, Sacramento. Observation year 2024. Accessed 2026-11-05. Cited in chapter 6, chapter 8
  26. 26Santhosh, C., Elon Musk’s Neuralink says it has 21 participants enrolled in trials (Reuters, 28 January 2026, read as published by The Star; company statement of 21 participants enrolled worldwide, up from 12 in September 2025). News agency report of a company statement, weak evidence. Reuters, London. Observation year 2026. Accessed 2026-11-05. Cited in chapter 8
  27. 27Paradromics (ed.), Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus Brain-Computer Interface (company release of November 2025, read as reposted by BioSpace; IDE approval for an early feasibility study that will initially enrol two participants at three sites). Company statement, weak evidence. Paradromics, Austin. Observation year 2025. Accessed 2026-11-05. Cited in chapter 4, chapter 8
  28. 28Medtronic (ed.), Medtronic receives FDA approval for BrainSense Adaptive DBS technology (company release republished by News-Medical, 3 March 2025; FDA approval of adaptive deep brain stimulation and the BrainSense Electrode Identifier for Parkinson disease). Company statement, weak evidence. Medtronic, Dublin. Observation year 2025. Accessed 2026-11-05. Cited in chapter 8
  29. 29Mordor Intelligence (ed.), Brain-computer Interface Market Size and Share Analysis (report page updated 3 August 2026; USD 1.27 billion in 2025) and TechSci Research (ed.), Brain Computer Interface Market (report page, January 2026; USD 2.57 billion in 2025). Market-research pages, weak evidence; figures differ about twofold and none is used. Observation year 2025. Accessed 2026-11-05. Cited in the summary, chapter 1, chapter 6, chapter 8
  30. 30Synchron (ed.), Synchron Raises USD 200 Million Series D to Advance Brain-Computer Interface Technology (Business Wire release as reproduced by I-Connect007, 7 November 2025; total funding USD 345 million). Company statement, weak evidence; no figure used. Synchron, New York. Observation year 2025. Accessed 2026-11-05. Cited in chapter 4, chapter 6, chapter 8
  31. 31OECD (ed.), Recommendation of the Council on Responsible Innovation in Neurotechnology, OECD/LEGAL/0457, adopted 11 December 2019 (instrument text opened). Organisation for Economic Co-operation and Development, Paris. Observation year 2019. Accessed 2026-11-05. Cited in chapter 4, chapter 6, chapter 8
  32. 32Kaifosh, P., Reardon, T.R. and CTRL-labs at Reality Labs, A generic non-invasive neuromotor interface for human-computer interaction, Nature 645, 702 to 711, 2025 (Crossref record). Springer Nature, London. Observation year 2025. Accessed 2026-11-05. Cited in chapter 8
  33. 33Genser, J., Damianos, S. and Yuste, R., Safeguarding Brain Data: Assessing the Privacy Practices of Consumer Neurotechnology Companies (report for the Neurorights Foundation, April 2024; policy documents of 30 companies reviewed; no figure used). Neurorights Foundation, New York. Observation year 2024. Accessed 2026-11-05. Cited in chapter 6, chapter 8
  34. 34Yuste, R. et al., Four ethical priorities for neurotechnologies and AI, Nature 551, 159 to 163, 2017 (Crossref record). Springer Nature, London. Observation year 2017. Accessed 2026-11-05. Cited in chapter 6, chapter 8
  35. 35Ienca, M. and Andorno, R., Towards new human rights in the age of neuroscience and neurotechnology, Life Sciences, Society and Policy 13, 5, 2017 (Crossref record). Springer, Berlin. Observation year 2017. Accessed 2026-11-05. Cited in chapter 6, chapter 8
  36. 36Hochberg, L.R. et al., Neuronal ensemble control of prosthetic devices by a human with tetraplegia, Nature 442, 164 to 171, 2006 (Crossref record). Springer Nature, London. Observation year 2006. Accessed 2026-11-05. Cited in chapter 6
  37. 37Collinger, J.L. et al., High-performance neuroprosthetic control by an individual with tetraplegia, The Lancet 381, 557 to 564, 2013 (Crossref record). Elsevier, London. Observation year 2013. Accessed 2026-11-05. Cited in chapter 6
  38. 38Moses, D.A. et al., Neuroprosthesis for decoding speech in a paralyzed person with anarthria, New England Journal of Medicine 385, 217 to 227, 2021 (Crossref record). Massachusetts Medical Society, Waltham. Observation year 2021. Accessed 2026-11-05. Cited in chapter 6
  39. 39European Parliament and Council, Regulation (EU) 2017/745 of 5 April 2017 on medical devices, Annex XVI point 6 (equipment intended for brain stimulation that applies electrical currents or magnetic or electromagnetic fields that penetrate the cranium). Official Journal of the European Union L 117, 5 May 2017, Luxembourg. Observation year 2017. Accessed 2026-11-05. Cited in chapter 6, chapter 8
  40. 40ISO (ed.), ISO 14708-3:2017 Implants for surgery, Active implantable medical devices, Part 3: Implantable neurostimulators (ISO open-data deliverables record: published 12 April 2017; current, confirmed). International Organization for Standardization, Geneva. Observation year 2017. Accessed 2026-11-05. Cited in chapter 4, chapter 6, chapter 8
  41. 41Spivack, J. and Victory, C., State Neural Data Laws, Summer 2025 (Future of Privacy Forum chart, August 2025; Montana SB 163 adds neurotechnology data to the Genetic Information Privacy Act, effective 1 October 2025; Connecticut SB 1295 adds neural data to sensitive data under its data privacy act, most sections effective 1 July 2026). Secondary compilation; the state texts were not opened. Future of Privacy Forum, Washington. Observation year 2025. Accessed 2026-11-05. Cited in chapter 6, chapter 8
  42. 42Carey (ed.), Ley N 21.383: publican reforma constitucional para establecer el desarrollo cientifico y tecnologico al servicio de las personas (client alert, 3 November 2021; Law 21.383 published in the Diario Oficial on 25 October 2021; adds a final paragraph to Article 19 No. 1 on protecting brain activity and the information derived from it). Law firm summary; the official text page did not load. Carey, Santiago. Observation year 2021. Accessed 2026-11-05. Cited in chapter 6, chapter 8
  43. 43European Parliament and Council, Regulation (EU) 2024/1689 of 13 June 2024 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act), Article 5(1)(f) on AI systems to infer emotions in the workplace and education institutions, except for medical or safety reasons. Official Journal of the European Union, L series, 12 July 2024, Luxembourg. Observation year 2024. Accessed 2026-11-05. Cited in chapter 6, chapter 8
  44. 44Holt, K., Neuralink says the FDA designated its Blindsight implant as a breakthrough device (Engadget, 18 September 2024; company statement as reported). Trade press reporting a vendor announcement, weak evidence. Engadget, New York. Observation year 2024. Accessed 2026-11-05. Cited in chapter 8

C.2Publication record

발행

제목
Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces, Baseline Edition
시리즈
Reports · Exponential Technology Series XT-20
판
Baseline Edition 2026 · inaugural annual
버전
v1.0.0 · draft for stewardship review
Publication ID
NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0
근거 마감
30 September 2026
Publication date
2026년 10월
DOI
concept and version DOI at deposit

발행자

공식 발행인
The Global Centre for Risk and Innovation (GCRI), for the Nexus Consortium
장소
Toronto
편집자
Saeed Valadbaygi, Chief Steward and Managing Editor
관리 주체
GCRI · technical truth · the Global Risks Forum (GRF) · public meaning · the Global Risks Alliance (GRA) · capital meaning
라이선스
text CC BY 4.0; data on the terms of each source
Copyright
© 2026 GCRI · Nexus Consortium
언어
English (en-GB) source edition
Correspondence
Registry correction pathway · editorial office

Colophon

형식
A4 portrait · screen, print and archival PDF
Typefaces
Space Grotesk (display) · Geist (text) · IBM Plex Sans Italic (standfirsts) · IBM Plex Mono (data)
Design standard
Reports Foundational Edition, Volume I, Part VII
접근성
tagged PDF and HTML targets; text alternatives for every figure
생산
Reports editorial team, GCRI

Release path for this version

Table C.1Release path for this version
단계진행 내용언제
초안editorial self-check complete at evidence close2026년 10월
Steward reviewfive passes on the exact draft (keys T · M · F · N)Q4 2026
승인publication authority approves the exact digestbefore release
Depositconcept and version DOI minted; registry pointer setat release
승계the 2027 neurotechnology edition reports changes against this baseline2027
Current version
v1.0.0 draft, stewardship review
Previous edition
none, first edition of the series
Next edition
NR-XTECH-NEURO-GLOBAL-2027-v1.0.0
Latest version
resolve the concept DOI or the registry record
Correction route
Registry correction pathway
Notice types
erratum · addendum · supersession · withdrawal

C.3정정 기록

0correction notices. No edition has been released yet, so none can be corrected; the log below lists each edition’s current version.

판버전날짜상태변화공지
XT-20NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.02026년 10월초안Baseline Edition 2026, inaugural annual edition,없음

Notice types: erratum, addendum, supersession, withdrawal. A correction is a new version with a published notice; the earlier version stays resolvable, and no edition is ever edited in silence.

C.4Open record

This edition’s open record

Publication ID
NR-XTECH-NEURO-GLOBAL-2026-BASELINE-v1.0.0
Desk identifier and series alias
NR-GCRI-XT-20-2026-BASELINE-v1.0.0 · NR-XTC-XT-20-2026-BL
Collection
NR-COL-2026-BASELINE (IsPartOf at deposit)
DOI
Concept and version DOI at deposit, on Zenodo with DataCite metadata
버전
Each correction is a new version (isNewVersionOf); the concept DOI resolves to the latest
Bundle
RO-Crate 1.2 with CITATION.cff, CodeMeta and PROV-O provenance; a signed manifest
라이선스
CC BY 4.0 (SPDX CC-BY-4.0) for original material; metadata CC0 1.0

Credit and identity

ORCID
Your iD in the deposit and the contribution record; DataCite can then add the work to your ORCID record
ROR
Your organisation by its ROR identifier, never by a typed name alone
CRediT
Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualisation, Writing, review and editing
계정
None needed to contribute; never a password

Find and follow

Search the open indexes for Neurotechnology and Human–Machine Interfaces; software is cited by its SWHID from Software Heritage, and a quantified scenario run is preregistered on OSF before it is run. Annotation is your choice: Hypothesis opens this page in its own viewer.

Mirrors and harvest

The DOI is canonical. At release each signed bundle is also given an IPFS content identifier and a bloxberg anchor as mirrors; both are listed in the record once they exist. Zenodo exposes every record over OAI-PMH, and reviews and endorsements can arrive through COAR Notify where the repository supports it.

InvenioRDM metadata for a contribution on Neurotechnology and Human–Machine Interfaces, prefilled from this page
{
  "metadata": {
    "resource_type": {
      "id": "dataset"
    },
    "title": "Evidence on Neurotechnology and Human–Machine Interfaces for Nexus Reports",
    "publication_date": "YYYY-MM-DD",
    "creators": [
      {
        "person_or_org": {
          "type": "personal",
          "family_name": "Your family name",
          "given_name": "Your given name",
          "identifiers": [
            {
              "scheme": "orcid",
              "identifier": "0000-0000-0000-0000"
            }
          ]
        },
        "affiliations": [
          {
            "id": "ROR identifier of your organisation"
          }
        ]
      }
    ],
    "description": "What it is, where its record is kept and how it bears on Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces.",
    "rights": [
      {
        "id": "cc-by-4.0"
      }
    ],
    "subjects": [
      {
        "subject": "Nexus Reports"
      },
      {
        "subject": "Neurotechnology and Human–Machine Interfaces"
      },
      {
        "subject": "Exponential Technology Report · XT-20"
      }
    ],
    "related_identifiers": [
      {
        "identifier": "https://therisk.global/nexus-reports/editions/xt-20/",
        "scheme": "url",
        "relation_type": {
          "id": "issupplementto"
        },
        "resource_type": {
          "id": "publication-report"
        }
      }
    ],
    "version": "1.0.0"
  },
  "custom_fields": {},
  "access": {
    "record": "public",
    "files": "public"
  },
  "files": {
    "enabled": true
  },
  "parent": {
    "communities": {
      "default": "nexusreports"
    }
  }
}

C.5Where this edition sits among the six pillars

Foundry seals the evidence and Universe tests it; Reports publishes it; Standards takes its corrections and Academy teaches from it.

  1. F03 Sealed observations and indicator series Foundry Sealed observations and indicator series behind a profile (closeout).
  2. F04 After-action and scenario findings for Universe After-action and scenario findings for chapters 10 and 13 (after action review).
  3. F05 National Portfolio movement for chapter Foundry National Portfolio movement for chapter 11 (after action review).
  4. Applied in editions Standards Nexus Standards: applied in editions.
  5. XT-20 edition Reports Neurotechnology and Human–Machine Interfaces 2026, published in every format with its sources, citation and corrections.
  6. F06 Method and correction findings as change Standards Method and correction findings as change proposals (correction).
  7. F12 Q4 synthesis informs the next-year Universe Q4 synthesis informs the next-year mandate (renewal).
  8. Taught in the open Academy Risk Academy: taught in the open.

What Foundry and Universe hand to this edition, and what it hands to Standards, Universe and Academy. From the programme spine; XT-20 is a drafted Baseline Edition, so these handoffs run from its first operational quarter.

인계BetweenWhat crosses, and when
F03Foundry to ReportsSealed observations and indicator series behind a profile (closeout).
F04Universe to ReportsAfter-action and scenario findings for chapters 10 and 13 (after action review).
F05Foundry to ReportsNational Portfolio movement for chapter 11 (after action review).
RingNexus Standards to ReportsNexus Standards: applied in editions.
F06Reports to Nexus StandardsMethod and correction findings as change proposals (correction).
F12Reports to UniverseQ4 synthesis informs the next-year mandate (renewal).
RingReports to Risk AcademyRisk Academy: taught in the open.

Downloads

Draft, not yet releasedReview copies of a draft in stewardship review. The released edition carries its DOI and replaces them.

  • 인쇄

    • PDF, A4

      The designed print edition, A4: cover, imprint and licence, how to cite, contents with page numbers, every chapter, figure, table and annex.

      PDF113 pages1.1 MBTagged, with bookmarks

      SHA-256 1b276afce6bca24b54678af9a98bba706f7ae5b11f20c2e49c30c56bd83684a0

    • PDF, US Letter

      The designed print edition, US Letter: cover, imprint and licence, how to cite, contents with page numbers, every chapter, figure, table and annex.

      PDF121 pages1.1 MBTagged, with bookmarks

      SHA-256 d43ae78f5a47684feb2d0ecc78a28696fdf3670c30a7369d28936ab2abf77a4a

  • Web edition

  • 데이터 번들

    • Indicators, CSV

      16 indicators with unit, year, status and source

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE-indicators.csv1 KB

      SHA-256 5fcebba27a41f952eb1984a1849d9a21e636ecbbb858a7cfd12593273299e02e

    • Indicators, JSON

      The same indicators with the edition’s identity and licence

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE-indicators.json2 KB

      SHA-256 84763ac2fc518c6e22a607df96e5cf665b378b7e2d5dae3a93a829a6138395b1

    • Findings, CSV

      12 findings with status, evidence-quality level and references

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE-findings.csv3 KB

      SHA-256 99d3e17ea329a61d07269b9c4fb66f9314005dd8eda895cb760a597a576e78e1

  • Citation files

    • Citation, BibTeX

      For LaTeX and reference managers

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE.bib1 KB

      SHA-256 631475c69ecb50a19d76d32931ee2d52190921f1d60804bf5ca3dc98f8422667

    • Citation, RIS

      For Zotero, EndNote and Mendeley

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE.ris1 KB

      SHA-256 cf6afd1f58373a90a8aa13996d249bb4d58205060d117a68bd590c7011178224

    • Citation, CITATION.cff

      Citation File Format 1.2.0, for GitHub, Zenodo and software catalogues

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE.cff1 KB

      SHA-256 fe34e2f10f3e0a3621cd4df996367019140db054e8d7d94f0890286aba3f630e

Check a file with its SHA-256: shasum -a 256 <file> (macOS, Linux) or Get-FileHash <file> (Windows). Text, tables and figures by Nexus: CC BY 4.0; each source keeps its own licence.

Cite this annex

Valadbaygi, S. (Ed.). (2026). Annex C: References and record. In Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces (Baseline Edition 2026, Report No. NR-XTECH-NEURO-GLOBAL-2026-BASELINE) [Draft under review]. The Global Centre for Risk and Innovation (GCRI).

Every citation form of the whole report, BibTeX and RIS included, is on the edition home. Cite this report

보고서기여하기

Send evidence or a correction on Neurotechnology and Human–Machine Interfaces.

Reports is the Consortium’s quarterly publication, written by six desks. This page sits with the GCRI Systems Evidence desk. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work. Sent to the wrong desk, it is forwarded, not refused.

GCRI 시스템 증거 담당 부서기하급수 기술

CC BY 4.0 Free to read. Text and figures: CC BY 4.0. Data: CC0 1.0. Authors keep copyright. Published by GCRI Canada.